About the Study Drug

What is the study drug?

The investigational study drug, known as felzartamab, is a monoclonal antibody, which is an antibody that is made in a laboratory. This antibody is designed to block the activity of cells and the substances they produce from attacking the kidney in lupus nephritis. This may help improve your symptoms and prevent the condition from getting worse.

Will I receive the study drug?

Yes, every participant will receive the investigational study drug with no chance of receiving a placebo.

What is an “investigational” drug?

Investigational means the study drug is not approved by regulatory authorities like the US Food and Drug Administration (FDA), and it can only be used in clinical research studies like the HIB-202-101 study.